Toth Financial Advisory Corp Pacira Bio Sciences, Inc. Transaction History

Toth Financial Advisory Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$27.7 - $35.48 $277 - $354	-10 Reduced 0.75%	1,332 $38,000
Q4 2023 Jan 26, 2024	SELL	$26.32 - $34.31 $9,343 - $12,180	-355 Reduced 20.92%	1,342 $45,000
Q4 2022 Jan 24, 2023	SELL	$38.19 - $57.45 $4,773 - $7,181	-125 Reduced 6.86%	1,697 $0
Q2 2022 Jul 25, 2022	SELL	$51.49 - $81.64 $594,709 - $942,942	-11,550 Reduced 86.37%	1,822 $106,000
Q1 2022 Apr 26, 2022	BUY	$60.03 - $76.49 $734,707 - $936,161	12,239 Added 1080.23%	13,372 $1.02 Million
Q2 2021 Jul 26, 2021	SELL	$59.18 - $69.99 $1.05 Million - $1.24 Million	-17,715 Reduced 93.99%	1,133 $69,000
Q1 2021 Apr 20, 2021	BUY	$59.31 - $78.82 $72,832 - $96,790	1,228 Added 6.97%	18,848 $1.32 Million
Q4 2020 Jan 25, 2021	BUY	$50.47 - $66.26 $144,091 - $189,172	2,855 Added 19.34%	17,620 $1.05 Million
Q3 2020 Oct 16, 2020	BUY	$51.97 - $63.0 $1,299 - $1,575	25 Added 0.17%	14,765 $888,000
Q2 2020 Jul 14, 2020	BUY	$30.8 - $52.47 $397,012 - $676,338	12,890 Added 696.76%	14,740 $773,000
Q1 2020 Apr 20, 2020	BUY	$28.4 - $50.7 $52,540 - $93,795	1,850 New	1,850 $62,000

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $763M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.